MedPath

The study of the predictive factors for response to Tolvaptan in Liver cirrhosis patients with water retentio

Not Applicable
Conditions
iver cirrhosis with refractory water retention
Registration Number
JPRN-UMIN000021300
Lead Sponsor
Hokkaido University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

(1)The patients with allergy to Tolvaptan (2)The patients who is difficult to take Tolvaptan (3)The patients who is difficult to drink water (4)The anuric patients (5)Hypernatremia (6)The pregnant

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The change of urinary aquaporin-2 before and after the administration of Tolvaptan
Secondary Outcome Measures
NameTimeMethod
The change of urinary osomolality, body weight,urinary volume before and after the administration of Tolvaptan
© Copyright 2025. All Rights Reserved by MedPath